indocyanine green has been researched along with Epithelial Ovarian Cancer in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Agusti, N; Díaz-Feijoo, B; Grillo-Ardila, C; Izquierdo, N; Paredes, P; Torne, A; Vidal-Sicart, S; Viveros-Carreño, D | 1 |
Buderath, P; Kimmig, R; Mach, P | 1 |
Bizzarri, N; Corrado, G; Cosentino, F; Fagotti, A; Ghezzi, F; Nero, C; Scambia, G; Turco, LC; Uccella, S; Vargiu, V; Vizza, E | 1 |
Dowdy, SC; Low, PS; Randall, LM; Tanyi, JL; Wenham, RM | 1 |
Buda, A; Bussi, B; Corrado, G; Cutillo, G; Magni, S; Passoni, P; Vizza, E | 1 |
2 review(s) available for indocyanine green and Epithelial Ovarian Cancer
Article | Year |
---|---|
Sentinel lymph node detection in early-stage ovarian cancer: a systematic review and meta-analysis.
Topics: Carcinoma, Ovarian Epithelial; Coloring Agents; Female; Humans; Indocyanine Green; Lymph Node Excision; Lymph Nodes; Lymphadenopathy; Ovarian Neoplasms; Sentinel Lymph Node; Sentinel Lymph Node Biopsy | 2023 |
The role of sentinel-node biopsy in ovarian cancer.
Topics: Carcinoma, Ovarian Epithelial; Coloring Agents; Female; Humans; Indocyanine Green; Injections; Lymph Node Excision; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Technetium | 2020 |
3 trial(s) available for indocyanine green and Epithelial Ovarian Cancer
Article | Year |
---|---|
Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Aged; Carcinoma, Endometrioid; Carcinoma, Ovarian Epithelial; Coloring Agents; Feasibility Studies; Female; Humans; Indocyanine Green; Lymph Node Excision; Lymph Nodes; Middle Aged; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Ovarian Neoplasms; Pelvis; Preliminary Data; Prospective Studies; Retroperitoneal Space; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Time Factors | 2019 |
A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Ovarian Epithelial; Coloring Agents; Cytoreduction Surgical Procedures; Female; Folate Receptor 1; Folic Acid; Humans; Indocyanine Green; Middle Aged; Ovarian Neoplasms; Prospective Studies; Spectroscopy, Near-Infrared; Surgery, Computer-Assisted | 2019 |
Near-infrared Fluorescence-guided Sentinel Node Mapping of the Ovary With Indocyanine Green in a Minimally Invasive Setting: A Feasible Study.
Topics: Adult; Aged; Carcinoma, Ovarian Epithelial; Endometrial Neoplasms; Feasibility Studies; Female; Humans; Indocyanine Green; Laparoscopy; Lymph Nodes; Middle Aged; Minimally Invasive Surgical Procedures; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Optical Imaging; Ovarian Neoplasms; Ovariectomy; Ovary; Sentinel Lymph Node Biopsy; Spectroscopy, Near-Infrared; Surgery, Computer-Assisted; Uterine Neoplasms | 2017 |